Role of BMI in the association of the TCF7L2 rs7903146 variant with coronary heart disease: The atherosclerosis risk in communities (ARIC) study

Journal of Obesity

Volumn 2010, Issue , 2010, Pages

  Kucharska Newton, Anna M ^a   Monda, Keri L ^a   Bielinski, Suzette J ^b   Boerwinkle, Eric ^c   Rea, Thomas D ^d   Rosamond, Wayne D ^a   Pankow, James S ^e   Köttgen, Anna ^f   Heiss, Gerardo ^a   North, Kari E ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83455258866     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2010/651903     Document Type: Article

References (14)

1. Cauchi S., Froguel P., TCF7L2 genetic defect and type 2 diabetes. Current Diabetes Reports 2008 8 2 149 155 10.1007/s11892-008-0026-x 2-s2.0-44849083863
2. Yan Y., North K. E., Ballantyne C. M., Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and Caucasian adults: the atherosclerosis risk in communities (ARIC) study. Diabetes 2008 58 285 289
3. Cauchi S., Choquet H., Gutierrez-Aguilar R., Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity 2008 16 2 476 482 10.1038/oby.2007.77 2-s2.0-39449114267 (Pubitemid 351271935)
4. Cauchi S., Nead K. T., Choquet H., The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Medical Genetics 2008 9, article 45 10.1186/1471-2350-9-45 2-s2.0-44649133311 (Pubitemid 351803796)
5. Helgason A., Palsson S., Thorleifsson G., Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 2007 39 2 218 225 10.1038/ng1960 2-s2.0-33846596193 (Pubitemid 46184353)
6. Stamler J., Vaccaro O., Neaton J. D., Wentworth D., Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993 16 2 434 444 2-s2.0-0027406191 (Pubitemid 23046633)
7. The ARIC Investigators, The Atherosclerosis Risk in Community (ARIC) study. Design and objectives. American Journal of Epidemiology 1989 129 687 702
8. Atherosclerosis Risk in Communities Study Manual E
9. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity 1998 Geneva, Switzerland World Health Organization. Consulation on Obesity
10. Bielinski S. J., Pankow J. S., Folsom A. R., North K. E., Boerwinkle E., TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2008 51 6 968 970 10.1007/s00125-008-1004-1 2-s2.0-43049135122
11. Yi F., Sun J., Lim G. E., Fantus I. G., Brubaker P. L., Jin T., Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells. Endocrinology 2008 149 5 2341 2351 10.1210/en.2007-1142 2-s2.0-42449134942 (Pubitemid 351574509)
12. Schafer S. A., Tschritter O., Machicao F., Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007 50 12 2443 2450 10.1007/s00125-007-0753-6 2-s2.0-35848942800 (Pubitemid 350060632)
13. Loder M. K., Xavier G. D. S., McDonald A., Rutter G. A., TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic Î2 -cells. Biochemical Society Transactions 2008 36 3 357 359 10.1042/BST0360357 2-s2.0-45249084351 (Pubitemid 351839331)
14. Ross S. E., Hemati N., Longo K. A., Inhibition of adipogenesis by Wnt signaling. Science 2000 289 5481 950 953 10.1126/science.289.5481.950 2-s2.0-0034637103 (Pubitemid 30659947)